AGH 3.4 -0.31 Vol 112860 AGL 16.45 0.00 Vol 10000 BAS 1.6 0.00 Vol 0 BFM 16.8 0.00 Vol 0 BG23B 98.0002 0.00 Vol 0 BPH 6.75 0.00 Vol 0 DEVON 4.25 0.00 Vol 0 LOM 2.5 0.00 Vol 0 NTB 50 0.50 Vol 12500 ONE 3.15 0.00 Vol 0 POLAR 5 0.00 Vol 0 SOM 16.25 0.00 Vol 0 WHHL 4.06 0.00 Vol 0 WWW 21.5 0.00 Vol 0
Market Open:
3 Burlington Road,
Dublin
Ireland, D04 RD68
Listed Since: 2017/10/11
Currency: USD
Telephone: 1-800-793-2145
Email: Gordon.Cox@estera.com

Pernix Ireland Pain Designated Activity Company (the “Issuer”) is a designated activity company limited by shares incorporated on 19 March 2015 under the laws of Ireland (registration number 559207). The Issuer is a direct and wholly owned subsidiary of Pernix Therapeutics Holdings, Inc. (organizational identification number D04539888), having its registered office at 10 North Park Place, Suite 201, Morristown, NJ 07960, United States. The Issuer’s registered office is located at 3 Burlington Road, Dublin 4, Ireland and its telephone number is 1-800-793-2145.

FINANCIAL AND OTHER INFORMATION

DIRECTORY

LISTING SPONSOR

TRADING HOURS

08:30-09:00 Price Discovery
09:00-16:30 Continuous Trading

CONTACT DETAILS

TEL: +1 (441) 292 7212
FAX: +1 (441) 292 7619
Email: info@bsx.com

LOCATION

30 Victoria Street
3rd Floor
Hamilton, Bermuda

MAILING ADDRESS

P.O. Box HM 1369
Hamilton HMFX

Disclaimer

 

The information contained in these pages has been obtained from sources which The Bermuda Stock Exchange believes are reliable. However, the accuracy of the information cannot and is not guaranteed and The Bermuda Stock Exchange makes no representation as to its accuracy or completeness. Neither this Web site, nor any information contained herein, constitutes advice or a solicitation to subscribe, purchase or sell any securities. The Bermuda Stock Exchange expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon any part of the contents of this site or any external sites referenced from this website.